









Markets
/
Stocks
/
nasdaq-vnrx
/

VolitionRX Ltd

VNRX

View Detailed Chart

0.640USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

64.48MMarket Cap

LossP/E TTM



VolitionRX Ltd

0.640

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-4.87%

5 Days

-14.67%

1 Month

-13.51%

6 Months

+7.38%

Year to Date

+6.67%

1 Year

+0.58%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 5 analysts

BUY

Current Rating

3.128

Target Price

388.75%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

VolitionRX Ltd

VNRX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(2)

Buy(2)

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.024

Neutral

RSI(14)

43.005

Neutral

STOCH(KDJ)(9,3,3)

20.070

Sell

ATR(14)

0.058

Low Volatility

CCI(14)

-157.014

Sell

Williams %R

80.442

Oversold

TRIX(12,20)

0.060

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

0.684

Sell

MA10

0.715

Sell

MA20

0.696

Sell

MA50

0.664

Sell

MA100

0.587

Buy

MA200

0.612

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Ticker SymbolVNRX

CompanyVolitionRX Ltd

CEODr. Jasmine Kway

Websitehttps://volition.com/